Vice President of Chemistry @ Tollnine (May 2018 - October 2018)
Vice President and Head of Chemistry @ Ambrx (IPO and acquired by JnJ) (October 2018 - December 2021)
Executive Director and Head of Chemistry @ Solstice Biologics (January 2015 - December 2017)
Director and Head of Chemistry @ Solstice Biologics (November 2012 - December 2014)
Director of Chemistry @ Traversa Therapeutics (May 2010 - March 2012)
Director of Chemistry @ Orchid Research Labs Ltd (November 2007 - October 2009)
Senior Scientist @ CovX (acquired by Pfizer) (May 2004 - October 2007)
Senior Research Scientist @ Morphochem (June 2001 - May 2004)
Post Doctoral Fellow @ (June 1998 - May 2001)
Research Scientist @ AVRA Laboratories (April 1997 - June 1998)
Sukumar Sakamuri Education
Indian Institute of Chemical Technology (IICT), Hyderabad
Ph. D. (Organic Chemistry)
1991-1997
Sukumar Sakamuri Skills
Drug Discovery
Medicinal Chemistry
Peptides
Drug Design
Lead Change
Protein Chemistry
Chemistry
Peptide Synthesis
Antibodies
Organic Synthesis
Organic Chemistry
Small Molecules
HPLC
Drug Development
Management
Project Management
Healthcare
Customer Service
Sukumar Sakamuri Summary
Sukumar Sakamuri, based in San Diego, CA, US, is currently a Chief Technology Officer at Aro Biotherapeutics. Sukumar Sakamuri brings experience from previous roles at Tollnine, Ambrx (IPO and acquired by JnJ) and Solstice Biologics. Sukumar Sakamuri holds a 1991 - 1997 Ph. D. in Organic Chemistry @ Indian Institute of Chemical Technology (IICT), Hyderabad. With a robust skill set that includes Drug Discovery, Medicinal Chemistry, Peptides, Drug Design, Lead Change and more. Sukumar Sakamuri has 2 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Sukumar Sakamuri?
Find contact details for 700 million professionals.